<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04224649</url>
  </required_header>
  <id_info>
    <org_study_id>HU-055</org_study_id>
    <nct_id>NCT04224649</nct_id>
  </id_info>
  <brief_title>To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds</brief_title>
  <official_title>A Single Center, Randomized, Subject &amp; Evaluator-blind, Matched Pairs, Active-controlled Design Pivotal Study to Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huons Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Humedix Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Huons Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Investigational Device : HARA (Hyaluronic Acid Filler)

        -  Title : A Single center, Randomized, Subject &amp; Evaluator-blind, Matched pairs,
           Active-controlled design Pivotal study to Evaluate the Efficacy and Safety of Injection
           with HARA as Compared to Restylane® Lidocaine in temporary Correction of Nasolabial
           folds

        -  Sites and investigators : Chung-ang University Hospital(Seoul), Beom-Joon Kim, M.D, Ph.D

        -  Objective : To compare the non-inferiority of HARA with Restylane® Lidocaine for
           evaluation of the efficacy and safety on Nasolabial Folds
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment By independent evaluator</measure>
    <time_frame>Week 24 From baseline Visit(=Investigational Device Injection)</time_frame>
    <description>Wrinkle Severity Rating Scale (WSRS, Wrinkle severity Rating scale)
* Grade 1: Absent, Grade 2: Mild, Grade 3: Moderate, Grade 4: Severe, Grade 5: Extereme</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">67</enrollment>
  <condition>Nasolabial FOLD</condition>
  <arm_group>
    <arm_group_label>Test Device Group(HARA filler)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Group(Restylane® Lidocaine)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HARA Filler(Hyaluronic acid Filler)</intervention_name>
    <description>The same participants received the experimental device and the active comparator device at the same time (left and right sides of face).</description>
    <arm_group_label>Test Device Group(HARA filler)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane® Lidocaine</intervention_name>
    <description>The same participants received the experimental device and the active comparator device at the same time (left and right sides of face).</description>
    <arm_group_label>Comparator Group(Restylane® Lidocaine)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Those who agreed to this treatment and signed the Informed Consent Form

          2. Those who are 19 years old or more and desire to take correction of nasolabial folds

          3. Those who have an intention of refraining from other cosmetic treatment(other filler
             injection, laser or chemical peeling, Botox injection or wrinkle reduction) during the
             clinical study period

          4. Those whose Wrinkle Severity Rating Scale (WSRS) is more than 2 points at least

        Exclusion Criteria:

          1. Those who are sensitive to lidocaine or other amide anesthesia

          2. Those who are sensitive to control device

          3. Those who are pregnant or lactating, or expect pregnancy

          4. Those who are judged by the subinvestigator to be improper for this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Huons</name>
      <address>
        <city>Seongnam-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Choi Yubeen</last_name>
      <phone>07074925965</phone>
      <email>ybin9398@huons.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 5, 2019</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

